These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27215743)

  • 1. Clinical implications of serum IgG
    Woo YJ; Kim JW; Yoon JS
    Br J Ophthalmol; 2017 Mar; 101(3):256-260. PubMed ID: 27215743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease.
    Hong JW; Kang S; Song MK; Ahn CJ; Sa HS
    Br J Ophthalmol; 2018 Nov; 102(11):1591-1595. PubMed ID: 29420193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraorbital corticosteroid injection for the treatment of IgG4-related ophthalmic disease.
    Andrew NH; Gajdatsy A; Selva D
    Br J Ophthalmol; 2016 May; 100(5):644-7. PubMed ID: 26297732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Rise of Serum IgG4 Levels After Steroid Therapy for Autoimmune Pancreatitis Predicts the Likelihood of Relapse.
    Suzuki D; Shimizu K; Tokushige K
    Pancreas; 2018 Apr; 47(4):412-417. PubMed ID: 29517627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease.
    Park J; Lee MJ; Kim N; Kim JE; Park SW; Choung HK; Khwarg SI
    Br J Ophthalmol; 2018 Jun; 102(6):736-741. PubMed ID: 28972022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of Serum IgG4 in Patients with Ocular Adnexal Marginal Zone B Cell Lymphoma Associated with IgG4-Related Ophthalmic Disease After Treatment.
    Wu YH; Wang LC; Yen SH; Yu WK; Kao SC; Kau HC; Tsai CC; Liu CJ
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):543-548. PubMed ID: 28514197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids.
    Yu WK; Kao SC; Yang CF; Lee FL; Tsai CC
    Jpn J Ophthalmol; 2015 Jan; 59(1):8-13. PubMed ID: 25373451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India.
    Gupta N; Mathew J; Mohan H; Chowdhury SD; Kurien RT; Christopher DJ; Thangakunam B; Alexander M; Sivadasan A; Tamilarasi V; Valson AT; Gowri M; Kabeerdoss J; Danda D
    Rheumatol Int; 2018 Feb; 38(2):203-209. PubMed ID: 28550399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.
    Culver EL; Sadler R; Simpson D; Cargill T; Makuch M; Bateman AC; Ellis AJ; Collier J; Chapman RW; Klenerman P; Barnes E; Ferry B
    Am J Gastroenterol; 2016 May; 111(5):733-43. PubMed ID: 27091321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
    Wallace ZS; Deshpande V; Stone JH
    Semin Arthritis Rheum; 2014 Jun; 43(6):806-17. PubMed ID: 24513111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients.
    Campochiaro C; Ramirez GA; Bozzolo EP; Lanzillotta M; Berti A; Baldissera E; Dagna L; Praderio L; Scotti R; Tresoldi M; Roveri L; Mariani A; Balzano G; Castoldi R; Doglioni C; Sabbadini MG; Della-Torre E
    Scand J Rheumatol; 2016; 45(2):135-45. PubMed ID: 26398142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG4 disease.
    Yamamoto M; Hashimoto M; Takahashi H; Shinomura Y
    J Neuroophthalmol; 2014 Dec; 34(4):393-9. PubMed ID: 25405661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Symptom Duration and Serologic Factors in the Relapse of IgG4-Related Ophthalmic Disease following Surgery: A Retrospective Cohort Study.
    Liu S; Yue Z; Zeng C; Huang X; Li J; Diao J; Chen X; Wei R; Yang W
    Dis Markers; 2022; 2022():5651506. PubMed ID: 35256891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of disease relapse in IgG4-related disease following rituximab.
    Wallace ZS; Mattoo H; Mahajan VS; Kulikova M; Lu L; Deshpande V; Choi HK; Pillai S; Stone JH
    Rheumatology (Oxford); 2016 Jun; 55(6):1000-8. PubMed ID: 26888853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD.
    Andrew NH; Sladden N; Kearney DJ; Selva D
    Br J Ophthalmol; 2015 Mar; 99(3):376-81. PubMed ID: 25185258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease.
    Ngwa TN; Law R; Murray D; Chari ST
    Pancreas; 2014 Jul; 43(5):704-7. PubMed ID: 24632552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4-related disease: a rheumatologist's perspective.
    Soliotis F; Mavragani CP; Plastiras SC; Rontogianni D; Skopouli FN; Moutsopoulos HM
    Clin Exp Rheumatol; 2014; 32(5):724-7. PubMed ID: 25068679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG4-related disease: a neuro-ophthalmological perspective.
    Kashii S
    J Neuroophthalmol; 2014 Dec; 34(4):400-7. PubMed ID: 25405662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral IgG4-related ophthalmic disease: a strong indication for systemic imaging.
    Wu A; Andrew NH; McNab AA; Selva D
    Br J Ophthalmol; 2016 Oct; 100(10):1409-11. PubMed ID: 26719494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of relapse following glucocorticoid tapering in IgG4-related disease.
    Sasaki T; Akiyama M; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):186-189. PubMed ID: 29846165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.